Eject 137% in the stock after the positive results of the vaccine...
LAST INFORMATION 17.45 An experimental, personalized vaccine against cancer, developed by Merck and Moderna, recorded positive initial results in the first large-scale final phase study, the two companies announced on Wednesday, bringing it under development treatment a step closer to submitting an application for approval. The mRNA technology vaccine, combined with [...]





